JP2007516181A5 - - Google Patents

Download PDF

Info

Publication number
JP2007516181A5
JP2007516181A5 JP2006517573A JP2006517573A JP2007516181A5 JP 2007516181 A5 JP2007516181 A5 JP 2007516181A5 JP 2006517573 A JP2006517573 A JP 2006517573A JP 2006517573 A JP2006517573 A JP 2006517573A JP 2007516181 A5 JP2007516181 A5 JP 2007516181A5
Authority
JP
Japan
Prior art keywords
immune composition
immune
composition
composition according
administered
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2006517573A
Other languages
English (en)
Japanese (ja)
Other versions
JP2007516181A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2004/020121 external-priority patent/WO2005000345A2/en
Publication of JP2007516181A publication Critical patent/JP2007516181A/ja
Publication of JP2007516181A5 publication Critical patent/JP2007516181A5/ja
Pending legal-status Critical Current

Links

JP2006517573A 2003-06-23 2004-06-23 髄膜炎菌血清群ａおよびｃに対する免疫方法 Pending JP2007516181A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US48092503P 2003-06-23 2003-06-23
PCT/US2004/020121 WO2005000345A2 (en) 2003-06-23 2004-06-23 Immunization method against neisseria meningitidis serogroups a and c

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2011004664A Division JP2011074087A (ja) 2003-06-23 2011-01-13 髄膜炎菌血清群ａおよびｃに対する免疫方法

Publications (2)

Publication Number Publication Date
JP2007516181A JP2007516181A (ja) 2007-06-21
JP2007516181A5 true JP2007516181A5 (enExample) 2007-08-16

Family

ID=33551955

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2006517573A Pending JP2007516181A (ja) 2003-06-23 2004-06-23 髄膜炎菌血清群ａおよびｃに対する免疫方法
JP2011004664A Pending JP2011074087A (ja) 2003-06-23 2011-01-13 髄膜炎菌血清群ａおよびｃに対する免疫方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2011004664A Pending JP2011074087A (ja) 2003-06-23 2011-01-13 髄膜炎菌血清群ａおよびｃに対する免疫方法

Country Status (8)

Country Link
US (1) US20050019337A1 (enExample)
EP (2) EP1644036A2 (enExample)
JP (2) JP2007516181A (enExample)
AU (2) AU2004251742A1 (enExample)
BR (1) BRPI0411875A (enExample)
CA (1) CA2530434A1 (enExample)
MX (1) MXPA05014171A (enExample)
WO (1) WO2005000345A2 (enExample)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX339524B (es) 2001-10-11 2016-05-30 Wyeth Corp Composiciones inmunogenicas novedosas para la prevencion y tratamiento de enfermedad meningococica.
RU2379052C2 (ru) 2004-04-30 2010-01-20 Чирон С.Р.Л. Вакцинация менингококковыми конъюгатами
GB0500787D0 (en) 2005-01-14 2005-02-23 Chiron Srl Integration of meningococcal conjugate vaccination
GB0505518D0 (en) 2005-03-17 2005-04-27 Chiron Srl Combination vaccines with whole cell pertussis antigen
HUE045482T2 (hu) 2005-06-27 2019-12-30 Glaxosmithkline Biologicals Sa Immunogén készítmény
KR101838938B1 (ko) * 2006-03-17 2018-03-15 더 거버먼트 오브 더 유나이티드 스테이츠 오브 아메리카 에즈 레프리젠티드 바이 더 세크러테리 오브 더 디파트먼트 오브 헬스 앤드 휴먼 서비시즈 복합 다가 면역원성 콘쥬게이트의 제조 방법
US10828361B2 (en) 2006-03-22 2020-11-10 Glaxosmithkline Biologicals Sa Regimens for immunisation with meningococcal conjugates
NZ572054A (en) 2006-03-22 2011-12-22 Novartis Ag Regimens for immunisation with meningococcal conjugates
US8414899B2 (en) 2006-04-11 2013-04-09 Yeda Research And Development Co. Ltd. Vaccines comprising multimeric HSP60 peptide carriers
AR064642A1 (es) 2006-12-22 2009-04-15 Wyeth Corp Polinucleotido vector que lo comprende celula recombinante que comprende el vector polipeptido , anticuerpo , composicion que comprende el polinucleotido , vector , celula recombinante polipeptido o anticuerpo , uso de la composicion y metodo para preparar la composicion misma y preparar una composi
CA2808975C (en) 2010-08-23 2018-10-30 Wyeth Llc Stable formulations of neisseria meningitidis rlp2086 antigens
KR101584871B1 (ko) 2010-09-10 2016-01-22 와이어쓰 엘엘씨 네이세리아 메닝기티디스 orf2086 항원의 비-지질화된 변이체
CA2865745C (en) 2012-03-09 2018-01-09 Pfizer Inc. Neisseria meningitidis compositions and methods thereof
SA115360586B1 (ar) 2012-03-09 2017-04-12 فايزر انك تركيبات لعلاج الالتهاب السحائي البكتيري وطرق لتحضيرها
EP2852414B9 (en) 2012-05-22 2020-12-09 GlaxoSmithKline Biologicals SA Meningococcus serogroup x conjugate
CA2903716C (en) 2013-03-08 2019-04-09 Pfizer Inc. Immunogenic fusion polypeptides
RU2662968C2 (ru) 2013-09-08 2018-07-31 Пфайзер Инк. Иммуногенная композиция против neisseria meningitidis (варианты)
IL312865B2 (en) 2013-09-11 2025-06-01 Eagle Biologics Inc Liquid protein formulations containing viscosity-lowering agents
SG11201702614SA (en) * 2014-10-01 2017-04-27 Eagle Biolog Inc Polysaccharide and nucleic acid formulations containing viscosity-lowering agents
KR20190049940A (ko) 2015-02-19 2019-05-09 화이자 인코포레이티드 나이세리아 메닌지티디스 조성물 및 그의 방법
SG11201906519RA (en) 2017-01-31 2019-08-27 Pfizer Neisseria meningitidis compositions and methods thereof
CA3155669A1 (en) 2019-09-27 2021-04-01 Pfizer Inc. Neisseria meningitidis compositions and methods thereof

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4356170A (en) 1981-05-27 1982-10-26 Canadian Patents & Development Ltd. Immunogenic polysaccharide-protein conjugates
US4673574A (en) 1981-08-31 1987-06-16 Anderson Porter W Immunogenic conjugates
US4644059A (en) 1982-07-06 1987-02-17 Connaught Laboratories, Inc. Haemophilus influenzae B polysaccharide-diptheria toxoid conjugate vaccine
US4619828A (en) * 1982-07-06 1986-10-28 Connaught Laboratories, Inc. Polysaccharide exotoxoid conjugate vaccines
US5153312A (en) 1990-09-28 1992-10-06 American Cyanamid Company Oligosaccharide conjugate vaccines
US5422427A (en) 1991-09-17 1995-06-06 The United States Of America As Represented By The United States Department Of Health And Human Services Pneumococcal fimbrial protein A
FR2682388B1 (fr) 1991-10-10 1995-06-09 Pasteur Merieux Serums Vacc Procede de preparation d'un oligoside par depolymerisation d'un polyoside issu d'un agent pathogene, oligoside ainsi obtenu et son utilisation notamment comme agent vaccinal.
US5445817A (en) 1992-08-21 1995-08-29 The United States Of America As Represented By The Department Of Health And Human Services Pertussis toxin used as a carrier protein with non-charged saccharides in conjugate vaccines
US5425946A (en) 1992-08-31 1995-06-20 North American Vaccine, Inc. Vaccines against group C Neisseria meningitidis
US5965714A (en) * 1997-10-02 1999-10-12 Connaught Laboratories, Inc. Method for the covalent attachment of polysaccharides to protein molecules
GB9806456D0 (en) * 1998-03-25 1998-05-27 Smithkline Beecham Biolog Vaccine composition
US6146902A (en) 1998-12-29 2000-11-14 Aventis Pasteur, Inc. Purification of polysaccharide-protein conjugate vaccines by ultrafiltration with ammonium sulfate solutions
EP1946769B1 (en) * 2000-06-29 2012-05-30 SmithKline Beecham Biologicals S.A. Multivalent vaccine composition with reduced dose of Haemophilus influenzae type B
GB0108364D0 (en) * 2001-04-03 2001-05-23 Glaxosmithkline Biolog Sa Vaccine composition
CA2435681C (en) * 2001-01-23 2011-06-21 Aventis Pasteur Multivalent meningococcal polysaccharide-protein conjugate vaccine
AU2002309706A1 (en) * 2001-05-11 2002-11-25 Aventis Pasteur, Inc. Novel meningitis conjugate vaccine
DK1587537T3 (da) * 2003-01-30 2012-07-16 Novartis Ag Injicerbare vacciner mod multiple meningococ-serogrupper

Similar Documents

Publication Publication Date Title
JP2005504718A5 (enExample)
JP2004501873A5 (enExample)
JP2007516219A5 (enExample)
JP2011042693A5 (enExample)
UA92579C2 (ru) Поливалентная менингококовая полисахаридно-белковая конъюгированная вакцина
RU2378009C2 (ru) Иммунизация против менингококков серогруппы y с помощью белков
ES2707294T3 (es) Composición inmunogénica
JP2005526847A5 (enExample)
RU2006114677A (ru) Жидкие вакцины для множественных серогрупп менингококков
RU2009149359A (ru) Состав вакцин против менингита
JP2007507487A5 (enExample)
RU2008112289A (ru) Множественная вакцинация, включающая менингококки серогруппы с
JP2005508849A5 (enExample)
JP2014506916A5 (enExample)
JP2008526939A5 (enExample)
JP2005531614A5 (enExample)
DK2200642T3 (da) Meningococvaccinepræparater
RU2004136295A (ru) Комбинированные вакцины против бактериального менингита для введения через слизистую оболочку
JP2006528936A5 (enExample)
JP2008543904A5 (enExample)
HRP20110685T1 (hr) Cjepivo od konjugata pneumokoknog polisaharida
TR201808055T4 (tr) Kapsüler polisakaritlerin çözünürleştirilmesi ve kombinasyon aşıları.
JP2006512402A5 (enExample)
FI3501534T3 (fi) Rokotekoostumuksia, jotka käsittävät mutatoitua tekijä h:ta sitovaa proteiinia
ATE463261T1 (de) Meningokokken-konjugat-impfung